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BioThrive supplement is a proprietary blend of plasma fractions including serum-
based bioactive proteins. The objective of this study was to evaluate the effect of
dosing BioThrive of porcine origin to mares on serum metabolites and stress bio-
markers of mares and their foals during late pregnancy, at parturition, and at 30 and
60 days of lactation. In addition, speciﬁc reference values for serum parameters of
mares and their foals were reported. Pregnant mares (n ¼ 26) housed in two barns,
Ask (n ¼ 11) and Blue Hors (n ¼ 15) were assigned to either a placebo (n ¼ 13) or
BioThrive (n ¼ 13) supplement (240 grams per day) that was divided into two daily
doses starting on average 55 days before foaling until approximately 60 days after
foaling. Mare body weight (BW) was recorded at 5, 5, 30, and 60 days of parturition.
Serum samples from mares were collected prepartum at an average of 55 days before
and 5, 30, and 60 days after parturition. Foal BW was recorded, and serum samples
were collected from foals at birth, 30, and 60 days of age. Mares given BioThrive had a
tendency for lower (P ¼ .069) BW at birth and had a tendency (P ¼ .072) for less TNF-a
during pregnancy and higher IgG at foaling (P ¼ .020). Foals from mares given Bio-
Thrive supplement had a tendency for reduced TNF-a at foaling (P ¼ .097). Results may
suggest that BioThrive had some effect on certain stress biomarkers in mares fed with
this supplement.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
BioThrive is derived from plasma proteins and is
a complex mixture of serum-based bioactive proteins
containing immunoglobulins, glycoproteins, growth
factors, and other physiological components that provideope, S.A. Research &
258 P.I., El Congost,
olo).
rs. Published by Elsevier Inantibacterial [1–3], anti-inﬂammatory effects [4–7],
improved intestinal barrier function [6,8], and other bene-
ﬁcial effects [7].
Stress may interfere with proper functioning of the
endocrine system, immune system, or both, resulting in
impaired fetal growth and reproductive losses [9,10]. The
beneﬁcial effects of bioactive proteins present in BioThrive
on pregnant and lactating animals under stress may be due
tomodulation of the immune system [4,11,12], and therefore,
a reduction of the negative effects associated with stressful
conditions, such as inﬂammation. Evidence in mice andc. This is an open access article under the CC BY-NC-ND license (http://
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tenance of pregnancy [13], fetal survival and growth [14],
and implantation of embryos [15]. Feeding spray-dried
plasma proteins (SDPs) to sows has moderately improved
some parameters of reproductive performance [16–18],
probably as a consequence of reduced inﬂammation.
In animal models, spray-dried plasma increased
maternal growth, number of fetuses, and fetal weight [19].
Thus, in theory, bioactive proteins contained in BioThrive
may improve overall well-being and reduce stress associ-
ated with pregnant and lactating mares and their foals.
Each animal species needs speciﬁc reference intervals of
biochemical parameters for an appropriate interpretation
of the results obtained from blood analysis. Moreover, each
analyte should have distinct reference intervals by age,
breed, and reproductive status [20].
The objectives of this studywere to evaluate the effect of
BioThrive dosed to mares during late pregnancy and early
lactation on various serum metabolites and stress
biomarkers and to determine whether signiﬁcant changes
occur in serologic parameters for mares and their foals
during late pregnancy, at parturition, and at 30 and 60 days
of lactation, andwhether changes are substantial enough to
establish speciﬁc reference intervals.2. Material and Methods
2.1. Ethic Statement
The experimental procedures with animals described in
this study were conducted after approval from the Animal
Protection Agency of Danish Ministry of Food, Agriculture





The study was conducted in two barns (Blue Hors and
Ask) during late pregnancy (last 1–2 months of pregnancy)
and the ﬁrst 2 months of lactation.
Twenty-nine pregnant dressage Warmbloods mares were
initially enrolled in this study, 17 from Blue Hors barn (BH)
and 12 from Ask barn (Ask). Of the initial 17 mares from BH,
one mare was euthanatized from BioThrive group due to
complications during foaling. One foal located in Ask was
euthanatized from placebo group due to complications of a
congenital cleft palate. One mare in BH allocated to the Bio-
Thrive group did not consume the supplement formost of the
66-day dosing period; consequently, this mare was not
included in the data analysis. Therefore, only 15 and 11mares
and foals fromBH andAsk, respectivelywere able to complete
the trial. At Ask, two mares and foals in the placebo group
were moved off site for 2 and 14 days, respectively, due to
inseminationwith cryopreserved sperm; therefore, themares
did not receive the placebo during this period. In addition, one
mare and foal in the BioThrive group were admitted to a
veterinary hospital for treatment for contracted tendons in
the foal, and the mare did not receive the supplement during
hospitalization. From the total 26 mares participating in the
study,13mareswere given the placebo (sevenmares from BHand six mares from Ask), and 13 mares were given BioThrive
(eight mares from BH and ﬁve mares from Ask). We used an
inclusion allocation determined by the estimated due date
(EDD), and the study period continued for 60 days after
foaling for each mare. Ideally, the mares were enrolled
approximately 60 days before EDD. Due to the timing of the
project, this was not possible with all horses.
The mares were assigned to either treatment 1 (placebo)
or treatment 2 (BioThrive) in a way that the proportion of
mares receiving either the placebo or BioThrivewas as evenly
distributed throughout the study as possible to have similar
weight, age, breed,parity, and size inboth thegroups. Average
age  standard error of the mean of mares in placebo or
BioThrive was 8.69 1.67 and 8.851.25 years, respectively,
and the range of ages of mares in both groups was from 4 to
19 years. Parities of the mares were 4.7  1.4 and 3.0  0.7
(average  standard error of the mean) for the placebo and
BioThrive groups, respectively. Both the groups followed the
same training and feeding program. All mares in both groups
were fed the same basal feed during the entire study period.
The study was blinded so that people dosing the
supplements and recording observations only knew the
color of the label (blue for placebo or red for BioThrive),
whereas people who knew the content of the two supple-
ments did not record observations. The mares had blood
samples taken at 60–30 days before EDD, within 48 hours
after foaling, as well as 30 and 60 days after foaling. The
foals were sampled between 24 and 48 hours after birth, as
well as 30 and 60 days after birth. In Ask, blood samples
were obtained during the morning, approximately at 8 AM.
In Blue Hors, blood samples were obtained either at
approximately 9 AM or at 1 PM.
The mares received a total of 240 g of supplement per
day, divided into two daily doses. The supplements in both
barns were given at approximately 6 AM to 7 AM and 5 PM.
When kept on pasture, the mares received the supplement
once daily at approximately 10 AM to 11:30 AM. Each
morning, the amount of supplement each horse had
consumed during the past 24 hours was recorded on the
data sheet. The weight of each mare was recorded
approximately 5 days before EDD as well as 5, 30, and
60 days after foaling. The weight of each foal was recorded
at birth and at 30 and 60 days after birth.
During the entire study period, the mares followed their
usual routines in regard to feeding, handling, and pasture
regimens. On dates blood sampling was scheduled, the
mares’ turn-out time was postponed until after sampling,
or the mares were turned out as usual, turned in for blood
sampling, and then back out again.
2.3. Supplements
The composition of BioThrive pellet used in the study is
proprietary, and the exact composition of the pellet cannot
be given; however, both supplements contained similar
amounts of calcium carbonate, calcium propionate, dehy-
drated alfalfa meal, molasses product, monocalcium
phosphate, natural and artiﬁcial ﬂavors, soybean hulls,
soybean oil, and wheat middling. BioThrive proteins of
porcine origin were substituted in equal amounts by 44%
soybean meal in the placebo group (Table 1).
Table 1
Analyzed composition of pelleted supplements.
Analyzed Values Placebo BioThrive
Dry matter (%) 89.07 89.58
Protein (%) 26.01 40.74
Ash (%) 9.52 8.14
Crude fat (%) 4.39 4.55
Crude ﬁber (%) 12.91 11.10
Porcine IgG (mg/g) d 10.40
Starch (%) 7.54 5.85
Calcium (%) 1.67 1.58
Phosphorous (%) 0.95 0.89
Sodium (%) 0.07 0.53
Chloride (in NaCl, %) 0.42 1.03
Chloride (in Cl, %) 0.25 0.62
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experimental feed mill facility of the institut de recerca en
tecnologia agroalimentaria of Catalonia (IRTA) in Mas de
Bover, Tarragona, Spain. Samples of supplements were
analyzed at an external laboratory (Ofﬁce, S.L., Barcelona,
Spain) for different components: dry matter (Association
of ofﬁcial agricultural chemists [AOAC] method 925.45),
crude protein (AOAC method 990.03), ash (AOAC method
942.05), crude fat (AOAC method 954.02), crude ﬁber
(AOAC method 962.09), starch (AOAC method 920.40),
sodium (AOAC method 985.35), phosphorous (AOAC
method 965.17), calcium (AOAC method 968.08), and
chloride (AOAC method 943.01). Porcine IgG was analyzed
by radial immunodiffusion (RID) using the method
described by Rodriguez et al [21] at the APC Europe, S.A.
Laboratory, Granollers, Spain.2.4. Blood Analysis
The blood samples from mares or foals were collected
by venipuncture of jugular vein using a 10-mL syringe
(Once; Dodan Deha, Denmark). For each mare, an 18-G
needle (Neolus, NN1838R; Terumo Denmark) was used,
and for each foal, a 21-G needle (Neolus, NN2138R; Terumo
Denmark) was used. The blood sample was transferred to
10-mL plastic tubes with beads to enhance coagulation. The
blood was allowed to coagulate at room temperature for
1 hour, and serum from the blood was collected after
centrifugation of the tubes at 3,000 rpm for 15 minutes and
stored at 20C until further analysis.
In each serum sample, the concentration of urea ni-
trogen, uric acid, and glucose was measured using an
automated clinical chemistry analyzer (Chemistry
Analyzer Olympus AU400; Beckman Coulter, Milan, Italy).
Equine IgG was analyzed by RID (Ref I-H-IgG-10., IDBio-
tech, Issoire, France). Cortisol was analyzed using a Sali-
vary Cortisol ELISA Kit (SLV-2930 from DRG Instruments,
Marburg, Germany), serum amyloid A (SAA) protein was
analyzed using a Multispecies SAA ELISA Kit (Tridelta
Development Ltd, Ireland), and TNF-a was analyzed using
an Equine TNF–a ELISA Kit (R&D Systems, Minneapolis,
MN).
Except for equine IgG, which was analyzed at the APC
Europe, S.A. Laboratory, Granollers, Spain, all other serumanalyses were done at the Servei de Bioquímica-Clínica
Veterinaria of Autonomous University of Barcelona.2.5. Statistical Analysis
There were a total of 26 mares used in the ﬁnal data
analysis for body weight (BW) and serology parameters.
Individual mare or foal was the experimental unit. There
were 11 and 15 mares and their foals kept at Ask and BH
barns, respectively. There were 13 and 13 mares given the
placebo and BioThrive supplement with six and seven
mares given the placebo at ASK and BH and ﬁve and eight
mares given BioThrive at ASK and BH, respectively. Data
sets for BW, BW change, and serology data by weight or
sampling period for mares or foals were analyzed using a
general linear model (PROC GLM, SAS Inst, Cary, NC) for
the effects of barn (ASK, BH), supplement (placebo, Bio-
Thrive) and the interaction of barn and supplement along
with the covariance of the initial data variable (i.e., BW or
serology variable for mare or foal). Also, the covariance of
sire of the foal, age of the mare, or parity of the mare was
considered in the statistical analysis for mare and foal BW
data. Least squares means of data variables for barn,
supplement, or barn by supplement are reported in the
following tables or ﬁgures. Signiﬁcance was considered at
probability of F-test at P < .05 with a tendency considered
at P > .05 and P < .10.
In addition to providing reference serology values for
mares and foals at various sampling periods, data for mares
or foals were analyzed using a mixed model for repeated
measures for effects and interactions of sampling period
and mare or foal within treatment as the subject effect
using PROC MIX, SAS Inst, Cary, North Carolina.
3. Results and Discussion
In this study, the mares kept at Blue Hors and Ask barns
had excellent facilities for managing pregnant mares with
plenty of free space for mares and foals. Both barns have
qualiﬁed horse managers and assistance of specialized
veterinary service to care for the horses. Based on this
management, it is assumed that the mares and foals
included in this study were not under environmental or
pathogen stress.
Of the mares receiving placebo supplement, all mares
accepted the supplement (100% consumption) within the
ﬁrst 10 days with a mean acceptance of 1.35 days. Of the
mares receiving BioThrive supplement, the earliest accep-
tance (100% consumption) occurred during the ﬁrst day;
however, mean acceptance was 12.5 days.3.1. Pregnant and Lactating Mares
The mares were included in the study at a mean of
56 days (range: 26–79 days) before EDD. At BH, the mares
were included at a mean of 60 days (range: 36–79 days)
before EDD, and at Ask, they were included at a mean of
51 days (range: 26–68 days) before EDD. Delivery dates
ranged from February 18, 2014 to July 6, 2014, with most of
the foals born between March and May.
Table 2
Summary of average body weight (BW) of the participant mares during the studya.
Barn Supplement
All Ask BH P Value Placebo BioThrive P Value
Number of mares 26 11 15 13 13
BW 5 d before foaling (kg) 684.9  12.7 699.2  20.4 675.4  16.7 .378 699.7  18.9 674.8  18.4 .355
BW 5 d after foaling (kg) 618.8  13.2 596.4 ± 7.1b 634.9 ± 5.8 .001 606.8 ± 6.6 624.5 ± 6.4 .069
BW 30 d after foaling (kg) 616.8  11.5 604.4 ± 7.7 623.8 ± 6.3 .068 612.1  7.2 616.0  6.9 .700
BW 60 d after foaling (kg) 619.0  11.4 607.5 ± 8.9 623.7 ± 6.8 .168 609.1  8.3 622.1  7.5 .262
BWD, 5 d AF versus 5 d BF (kg) 65.0  5.9 85.1 ± 7.1 50.1 ± 5.8 .001 78.0 ± 6.6 57.3 ± 6.4 .037
BWD, 30 d versus 5 d (kg) 2.0  5.2 8.0 ± 7.5 11.1 ± 6.1 .064 5.3  7.0 8.5  6.7 .173
BWD, 60 d versus 5 d (kg) 0.7  6.0 15.3 ± 8.8 10.8 ± 6.7 .030 6.4  8.2 2.0  7.4 .460
BWD, 60 d versus 30 d (kg) 3.5  3.9 7.7  6.9 0.2  5.3 .403 1.5  6.5 6.4  5.8 .583
a Values are as least squares means  standard error of the mean for barn or supplement. Mares were weighed at 5 days before foaling (BF), 5 days after
foaling (AF) and at 30 and 60 days AF. Mare BW or BW difference between weigh periods (BWD) data were analyzed using a general linear model for the
effects of barn (ASK, BH), supplement (placebo, BioThrive) and the interaction of barn and supplement along with the covariance of initial BW for mares.
b Values are in bold for easy differentiation of parameters with statistical signiﬁcance between treatments.
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the Study
There was no signiﬁcant interaction of supplement and
barn (data not shown) for mare BW parameters; thus, only
the main effects of barn or supplement are summarized in
Table 2.
Mares at Blue Hors had less weight loss (P ¼ .001) at
parturition, and this was consistent with lower birth
weight of foals (P ¼ .005). However, higher BW recovery
was observed for mares located at Ask during the next 30
(P¼ .064) and 60 (P¼ .030) days after delivery. Mares in BH
barn continued to have a tendency for higher BWat 30 days
(P ¼ .068) but not at 60 days, although these mares
continued to lose weight during the 60 lactation days
evaluated, whereas the mares in Ask did not lose weight
during the whole lactation period evaluated. Foals born at
BH had lower (P ¼ .005) BW at birth compared with foals
born at Ask (Table 3). The lower foal BW and the lower BW
loss by mares located at BH were not explained by differ-
ences among sires used at the different barns, as BH was
more oriented for dressage horses and Ask for jumping
horses. The covariance of sire did not have a signiﬁcant
inﬂuence on these results. Likewise, the covariance of mare
age or parity was not able to explain the signiﬁcant effects
reported for these results.
Mares dosed with BioThrive supplement had a ten-
dency for lower BW at foaling (P ¼ .069) compared withTable 3
Average body weight (BW) performance of foals during the study by barn and s
Barn
All Ask BH
Number of foals 26 11 15
BW at birth (kg) 56.6  1.7 61.2 ± 2.0b 53.0
BW at 30 d (kg) 105.1  2.8 110.0  3.6 101.6
BW at 60 d (kg) 140.8  3.7 141.8  4.0 140.3
BWD, 30 d versus birth (kg) 48.5  2.5 53.3  3.6 44.9
BWD, 60 d versus birth (kg) 84.4  2.5 85.3  4.0 83.7
BWD, 60 d versus 30 d (kg) 35.6  2.9 30.0  4.2 39.1
a Values are least squares means standard error of themean for barn or suppl
difference between periods (BWD) data were analyzed using a general linear mo
the interaction of barn and supplement along with the covariance of the initial B
b Values are in bold for easy differentiation of parameters with statistical signmares given the placebo, and their foals had a tendency
for lower birth weight (P ¼ .091). This effect has not been
observed before in different studies conducted with other
species (mice and sows) fed with bioactive proteins of SDP
[16,17,19]. However, feeding bioactive proteins from SDP to
mice increased the ratio between fetal weight and
placental weight [19] although the weight of the placenta
was similar in both the groups. Mares dosed with Bio-
Thrive or Placebo had similar BW at 30 or 60 days after
parturition, and no difference in BW loss or accretion
during lactation was observed between supplement
groups.
Body weight parameters for foals by the main effects of
barn and supplement dosed to their mare are summarized
in Table 3. The average birth BW for foals at BH was 8.2 kg
less than that in Ask (P ¼ .005), but the foal BW at 30 and
60 days was similar for both the barns. There was a
tendency (P ¼ .091) for lower BW at birth for foals in the
BioThrive group. However, there was a signiﬁcant interac-
tion of barn and supplement (P¼ .03) for the initial foal BW
(data not shown). Foals at Ask in the placebo group were
heavier than those in the BioThrive group (66.5 kg vs.
55.8 kg), whereas BW at birth did not differ much for foals
at BH barn in the placebo (52.2 kg) or BioThrive group
(53.7 kg). Subsequent analyses using the covariance of sire,
mare age, or parity did not alter the signiﬁcance of this
interaction, so, the reasons for differences in the initial BW
of foals at birth are not clear.upplementa.
Supplement
P Value Placebo BioThrive P Value
13 13
± 1.7 .005 59.4 ± 1.8 54.7 ± 1.9 .091
 3.1 .121 112.2 ± 3.2 99.4 ± 3.2 .012
 3.2 .795 144.1  3.5 137.9  3.3 .224
 3.1 .121 55.5 ± 3.2 42.8 ± 3.2 .012
 3.2 .795 87.7  5.5 81.5  3.3 .224
 3.3 .138 30.3  3.7 38.7  3.4 .122
ement. Foals were weighed at birth, 30, and 60 days of life. Foal BW and BW
del for the effects of barn (ASK, BH), supplement (placebo, BioThrive) and
W for foals.
iﬁcance between treatments.
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maintained at 30 days, but at 60 days after foaling, there
were no differences in BW between foals for either
supplement group. The main difference was observed
during the ﬁrst 30 days after birth, when the foals in the
placebo group gained an average 55.5 kg, whereas those in
the BioThrive group only gained 42.8 kg. During the second
month, a numerical increase in BW accretion was observed
for foals in the BioThrive group. These results differ from
other studies conducted with sows and mice in which the
neonates usually had a higher birth weight [19,22]. In
addition, a substantial amount of publications reported
increased BW during lactation in animals fed SDP
compared with control group [16–18,23]. The reasons for
the lowerweight gain during the initial month observed for
foals from mares dosed with BioThrive are unknown.
Nevertheless, in a study conducted by Donabédian et al [24]
with foals from birth to 1 year of age, fast growth was
positively correlated to the occurrence of some osteo-
chondrosis and other developmental orthopedic disease
lesions; therefore, the lower growth observed in foals from
the BioThrive group during the ﬁrst month may not be
regarded as a negative effect, as long as the foals were in
healthy status.
3.3. Health Performance and Medication in Foals
During the Study
No differences for health performance or medication
were observed in foals from mares receiving both supple-
ments or between barns. All foals receiving medical
treatments were for the treatment of pneumonia.Table 4
Reference values for different serology parameters of mares by period of the stu
Pregnancy Foaling
Glucose (mg/dL)
Average  SEM 116.50a  4.43 99.50c  2.8
Range 84.6–161.0 68.0–118.8
Urea (mg/dL)
Average  SEM 34.43c  1.34 41.41b  1.7
Range 23.30–48.10 27.40–59.20
Uric acid (mg/dL)
Average  SEM 0.23  0.02 0.23  0.0
Range 0.10–0.40 0.01–0.50
IgG (mg/mL)
Average  SEM 12.41  0.37 12.69  0.4
Range 9.30–16.84 8.20–16.40
Cortisol (ng/mL)
Average  SEM 23.48  4.50 21.70  3.3
Range 2.73–74.84 2.46–60.52
TNF-a (pg/mL)
Average  SEM 12,164  5,220 23,165  13
Range 0.9–107,000 0.9–286,217
SAA (mg/mL)
Average  SEM 7.00c  3.40 62.31b  13
Range 0.27–79.47 2.32–241.28
Abbreviation: SAA, serum amyloid A.
a Values are average  standard error of the mean (SEM) and range with minim
56.5 days (range 79–26 days) before foaling. Sampling at parturition averaged 1.5
30.5 days (range 26–38 days) after foaling, and sampling at 60 days of lactation a
Serology data were analyzed using a mixedmodel for repeatedmeasures for effec
subject effect.
b,c,d Per serum variables, means within row with uncommon superscripts diff3.4. Serology Results in Mares
Average and range of values for all serologic parameters
in mares are summarized in Table 4. Serologic analysis of
mares by barn, supplement, and barn by supplement during
the different periods analyzed is summarized in Table 5.
The glucose values reported for mares before, at partu-
rition, and 30 or 60 days after foaling are within reference
values for horses [20]. Higher levels of serum glucose were
observed during late pregnancy and at parturition, followed
by a progressive reduction during the post-foaling period. In
accordance with a previous study [25], glucose levels are
higher at parturition; however, we observed that glucose
values were still high during late pregnancy before parturi-
tion. Aoki and Ishii [25] hypothesized that it was related to
physical stress associated with foaling. Physical stress in-
creases the cortisol level [26], and cortisol promotes gluco-
neogenesis. However, we did not observe variation in
cortisol for mares over time during the study period. In
agreementwith a previous study [20], glucose concentration
was lower at 60 days after foaling than in late pregnancy and
foaling (P< .05). Because glucosemetabolism is well studied
in horses [27–29], it was assumed that it is the result of the
development of insulin resistance. Glucose regulation is
altered during pregnancy and lactation in many species,
including humans [30], laboratory animals [31], and pigs
[32]. Changes in glucose regulation during pregnancy
include progressive development of insulin resistance,
which allows for improved placental transfer of glucose to
meet the increasing demands of the fetus.
Glucose values inmares located in Askwere increased at
1 and 2 months after foaling compared with mares fromdya.
30-d Post-Foaling 60-d Post-Foaling
1 97.20c  4.31 87.10d  3.16
65.4–154.7 58.5–111.8
6 41.00b  1.74 38.85b  1.62
27.60–56.40 23.20–52.40
2 0.22  0.02 0.22  0.02
0.01–0.40 0.01–0.40
4 12.09  0.48 12.86  0.41
7.39–17.56 9.40–17.10
0 19.22  3.02 22.03  3.98
1.17–72.91 2.80–73.38
,357 17,173  11,837 15,420  11,521
0.9–295,532 0.9–285,960
.79 10.62c  5.00 13.83c  5.92
0.49–119.00 0.33–152.58
um and maximum values obtained. Sampling during pregnancy averaged
days (range 0–3 d) after foaling. Sampling at 30 days of lactation averaged
veraged 60.5 days (range 57–66 days) after foaling. There were 26 mares.
ts and interactions of sampling period andmare within treatment group as
er, P < .05.
Table 5
Serology results for mares by barn and supplementa.
Barn Supplement
Ask BH SEM P Placebo BioThrive SEM P
Glucose, mg/dL
Pregnancy 115.5 121.5 6.47 .488 126.3b 110.6 6.09 .079
Foaling 100.1 97.42 4.43 .659 95.23 102.2 4.31 .273
30 d AF 106.7 84.06 4.89 .002 90.56 100.2 4.76 .177
60 d AF 94.95 80.87 4.47 .027 86.01 89.80 4.35 .553
Urea, mg/dL
Pregnancy 37.12 31.11 1.9 .025 33.89 34.33 1.79 .862
Foaling 37.59 43.08 2.67 .767 38.71 41.97 2.36 .972
30 d AF 36.43 45.46 2.25 .009 40.73 41.16 1.99 .877
60 d AF 33.93 45.04 2.10 .001 41.70 37.33 1.85 .106
Uric acid, mg/dL
Pregnancy 0.298 0.186 0.03 .011 0.244 0.240 0.03 .922
Foaling 0.222 0.238 0.03 .675 0.238 0.222 0.02 .611
30 d AF 0.226 0.208 0.02 .430 0.217 0.216 0.01 .969
60 d AF 0.206 0.229 0.02 .306 0.207 0.228 0.01 .285
IgG, mg/mL
Pregnancy 13.22 11.53 0.51 .021 11.86 12.89 0.48 .144
Foaling 13.13 12.26 0.54 .255 11.82 13.57 0.49 .020
30 d AF 11.96 12.09 0.55 .869 11.57 12.48 0.50 .211
60 d AF 12.35 13.07 0.51 .317 12.28 13.14 0.46 .204
Cortisol, ng/mL
Pregnancy 27.85 20.10 6.99 .409 21.33 26.63 6.58 .571
Foaling 24.56 17.48 4.47 .244 21.65 20.39 4.19 .831
30 d AF 22.32 14.47 3.82 .135 16.26 20.53 3.58 .403
60 d AF 23.48 20.50 5.56 .690 21.53 22.44 5.22 .902
TNF-a, pg/mL
Pregnancy 15,631 8,690 7,909 .858 19,853 4,469 7,266 .072
Foaling 16,537 27,260 11,577 .491 26,816 16,981 11,056 .542
30 d AF 5,745 26,702 13,463 .252 19,056 13,391 12,857 .762
60 d AF 3,737 25,201 12,995 .225 17,270 11,668 12,410 .756
SAA, mg/mL
Pregnancy 6.83 6.93 5.28 .989 11.06 2.69 4.97 .241
Foaling 73.33 59.42 21.46 .627 84.18 48.58 20.51 .235
30 d AF 3.48 18.05 7.60 .160 15.92 5.62 7.27 .330
60 d AF 3.24 16.40 9.00 .279 17.41 2.22 8.61 .228
Abbreviation: SAA, serum amyloid A.
a Values are least squares mean for barn or supplement. There were 11mares in Ask and 15mares in BH. There were 13mares in the placebo group and 13
mares in the BioThrive-supplemented group. Samples during pregnancy were collected on average at56.5 days, range of79 to26 days before foaling. At
foaling, the samples were collected on average 1.5 days, range from 0 to 3 days after foaling. At 1 month after foaling (average 30.5 days, range 26–38 days)
and at 2 months after foaling (average 60.5 days, range 57–66 days). Data were analyzed by general linear model for effect and interactions of barn and
supplement with the covariance of initial serology variable.
b Values are in bold for easy differentiation of parameters with statistical signiﬁcance between treatments.
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differences were observed during pregnancy or at foaling.
Similarly, cortisol values were also numerically increased in
these mares at 30 days after foaling. This can be related
with higher physical stress of mares located in Ask and can
be correlated with the higher milk demand from foals from
Ask mares during the ﬁrst 30 days after foaling in which
these foals had increased body accretion. Glucose values
had a tendency to be lower (P ¼ .079) during pregnancy in
mares dosed with BioThrive, and this may be related with
lower physiological stress of the mares.
Urea nitrogen values in this study were within the
normal ranges reported for pregnant mares [20]. Urea
values were higher (P < .05) at delivery and remained
elevated during the next 2 months. These results are in
agreement with previous publication about mares during
the peripartum period [20]. Changes in serum urea may
reﬂect an increase in energy demand and a higher
requirement of amino acids for anabolic processes.
According to Mariella et al [20], urea nitrogen remainselevated, probably because of the high-energy demand at
the beginning of lactation [25]. In accordance with a
previous study, Aoki and Ishii [25] suggested that these
ﬁndings might be related to changes in energy meta-
bolism rather than in renal function. Urea and uric acid
values were also higher (P ¼ .025 and P ¼ .011, respec-
tively) in Ask mares during pregnancy (Table 5); however,
urea values were higher in mares located in BH at 30 and
60 days after foaling (P¼ .009 and P¼ .001). No differences
for urea and uric acid were observed between the two
supplemented groups.
Cortisol, TNF-a, and IgG were maintained at similar
average values during the whole study (Table 4). There
were no differences for cortisol values for the effect of barn
or supplement at any period analyzed (Table 5). TNF-awas
not different between barns, but mares dosed with
BioThrive supplement had a tendency (P ¼ .072) for lower
TNF-a values in serum during pregnancy (Table 5). TNF-a is
a pivotal pro-inﬂammatory cytokine that is released when
the immune system is activated, and the reduction
Table 6
Reference values for different serology parameters in foalsa.
Foaling 30 d of Age 60 d of Age
Glucose (mg/dL)
Average  SEM 161.4b  4.37 151.4b  2.40 138.7c  3.45
Range 101.6–189.7 127.0–170.9 95.9–174.6
Urea (mg/dL)
Average  SEM 24.80b  2.04 18.29c  1.24 21.29c  0.86
Range 11.30–54.60 10.60–35.20 13.90–32.90
Uric acid (mg/dL)
Average  SEM 0.17c  0.02 0.45b  0.04 0.51b  0.05
Range 0.10–0.40 0.10–0.70 0.10–0.80
IgG (mg/mL)
Average  SEM 10.99b  0.90 5.64c  0.55 7.62c  0.79
Range 1.35–18.35 0.07–10.68 3.49–24.69
Cortisol (ng/mL)
Average  SEM 12.63b  2.24 6.32c  1.43 6.43c  1.26
Range 0.20–51.40 0.22–22.90 0.20–29.21
TNF-a (pg/mL)
Average  SEM 8,894b  3,176 1,455c  567 2,178c  934
Range 10–50,665 10–11,415 10–21,685
SAA (mg/mL)
Average  SEM 275.8b  86.71 225.0b  130.74 8.37c  2.69
Range 5.80–1,534.7 1.62–3,060.9 0.48–58.30
Abbreviation: SAA, serum amyloid A.
a Values are expressed as average  standard error of the mean (SEM;
range with minimum and maximum values obtained). Samples were
collected at foaling and approximately 1 and 2months after foaling. There
were 26 foals in total. Foal serology data were analyzed using a mixed
model for repeated measures for effects and interactions of period and
foal within treatment group as subject effect.
b,c Per serum variables, means within rowwith uncommon superscripts
differ, P < .05.
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reduced immune activation and/or inﬂammation in these
mares. These results are consistent with previous publica-
tions in farm animals [6] and mice [33]. In a recent study,
adult performance horses given BioThrive had lengthened
stride of both front and hind limbs, along with enhanced
knee range of motion [34], both parameters related with
joint mobility. The lower TNF-a values for the BioThrive
group may suggest reduced inﬂammation in these mares.
Immunoglobulin G levels were higher for mares at Ask
(P ¼ .021) during pregnancy, but no differences were
observed for the rest of the periods. Mares dosed with
BioThrive supplement had higher (P ¼ .020) IgG values in
serum at foaling compared with mares given the placebo
and, in general, for all periods analyzed independent of the
barn. The mares dosed with BioThrive supplement consis-
tently over time had a numerically lower TNF-a, SAA, and
higher level of IgG in serum compared with mares given
the placebo. This may indicate better immune status for
mares dosed with the bioactive proteins present in the
BioThrive supplement.
Serum amyloid A protein increased at foaling and
reduced to normal values by 30 days after foaling (Table 4).
Serum amyloid A protein is a major rapid acute-phase pro-
tein that increases when there is tissue damage and then
declines rapidly, making it a good indicator of inﬂammation
and tissue damage. Results for SAA reported for mares are in
agreement with a previous publication for mares during
perinatal period [35]. Acute-phase SAAs are secreted during
the acute phase of inﬂammation. Serum amyloid A is also an
acute-phase marker that responds rapidly. Similar to C-
reactive protein, levels of acute-phase SAA increase within
hours after inﬂammatory stimulus. Relatively trivial in-
ﬂammatory stimuli can lead to SAA responses. It has been
suggested that SAA levels correlate well with disease activity
in early phase of inﬂammatory diseases [34]. It was inter-
esting also to observe that SAA was increased in both sup-
plemented groups and barns at parturition and reduced to
normal values rapidly after delivery. This is in agreement
with a previous publication inmares during perinatal period
[35]. This may indicate the stress associated with parturition
and potential immune activation.
3.5. Serology Results in Foals
Average and range of values for all serologic parameters
in foals are summarized in Table 6. These values are within
normal ranges previously described in foals [36]. The
serologic analysis of foals by barn, supplement, and barn by
supplement during the different periods are summarized in
Table 7.
In foals, glucose values were inside normal range
described for neonates and 1-month-old foals [36]. The
glucose values were higher at birth and continued to be
higher during the ﬁrst month of life, then declined to
normal values at 2months after birth (P< .05; Table 6). This
may suggest an acute gluconeogenesis process at birth,
which is in agreement with the high cortisol levels at birth
(P< .05). The glucose levels then declined to approximately
half the concentration after 1 month. This increase inglucose and cortisol at birth may be related to physical
stress associated with birth or to supply the higher energy
demand for foal development during the neonatal period.
Blood sampling can be of signiﬁcant inﬂuence for the
cortisol levels, and potentially the glucose levels as well.
Cortisol values were inside normal ranges for neonates
during all sampling periods [37]. No difference for cortisol
of foals from mares dosed with the two supplements were
found, but a tendency (P ¼ .068) was observed for higher
serum glucose values in foals from mares dosed with
BioThrive. Similarly, the levels of glucose were higher
(P ¼ .042) at birth in foals from mares located in Ask.
The urea values were higher (P < .05) at birth and
declined after 1 month of life (Table 6). As commented for
mares, changes in serum urea might reﬂect an increase in
energy demand and a higher need of amino acids for
anabolic processes during the ﬁrst few days after birth. Uric
acid values were approximately three-fold higher at 30 and
60 days of age (P < .05) compared with values at birth. In
addition, foals located at BH had lower uric acid at 1 and
2 months of life (P ¼ .001 and P < .001, respectively)
comparedwith foals located at Ask. No differences between
supplements were observed in foals for urea nitrogen or
uric acid.
The IgG values were higher (P < .05) at birth due to
maternal colostrum ingestion and were reduced by
almost half during the ﬁrst month of life (Table 6). The
IgG values for foals were not different between supple-
ments or barns during the whole study period (Table 7).
The values at birth were around 11 mg/mL, well over the
Table 7
Serology results for foals by barn and supplementa.
Barn Supplement
Ask BH SEM P Placebo BioThrive SEM P
Glucose, mg/dL
Foaling 170.0b 152.8 6.06 .042 153.7 169.0 5.71 .068
30 d AF 153.6 149.4 3.99 .450 153.2 149.8 3.74 .528
60 d AF 142.7 134.8 5.74 .321 134.7 142.9 5.38 .298
Urea, mg/dL
Foaling 21.44 28.17 3.08 .111 25.99 23.61 2.90 .563
30 d AF 17.95 18.80 2.03 .758 18.52 18.23 1.86 .911
60 d AF 20.83 21.84 1.42 .602 21.00 21.67 1.30 .715
Uric acid, mg/dL
Foaling 0.145 0.187 0.03 .240 0.168 0.164 0.02 .906
30 d AF 0.579 0.325 0.05 .001 0.470 0.434 0.05 .572
60 d AF 0.668 0.357 0.06 <.001 0.515 0.510 0.05 .946
IgG, mg/mL
Foaling 11.50 10.48 1.43 .595 10.89 11.08 1.35 .921
30 d AF 5.95 5.30 0.61 .430 5.67 5.59 0.57 .925
60 d AF 8.24 6.99 1.24 .454 7.45 7.77 1.17 .848
Cortisol, ng/mL
Foaling 14.38 10.89 3.55 .462 12.46 12.81 3.35 .940
30 d AF 5.41 7.08 1.73 .473 5.35 7.14 1.62 .437
60 d AF 5.81 7.03 1.99 .647 5.72 7.12 1.86 .595
TNF-a, pg/mL
Foaling 10,999 6,789 4,720 .505 14,281 3,507 4,443 .097
30 d AF 1949 892 708 .271 1987 855 681 .264
60 d AF 2977 1,202 855 .131 2024 2155 823 .914
SAA, mg/mL
Foaling 224.7 326.8 137.4 .578 278.3 273.3 129.4 .978
30 d AF 199.9 256.6 142.7 .766 69.69 386.9 133.9 .105
60 d AF 7.51 9.26 4.12 .752 3.66 13.11 3.87 .095
Abbreviation: SAA, serum amyloid A.
a Values are least squares mean for barn or for supplement. Samples were collected around time of foaling and at approximately 1 and 2 months after
foaling. There were 11 foals in Ask and 15 in BH. There were 13 foals frommares given the placebo and 13 foals frommares given the BioThrive supplement.
Data were analyzed by general linear model for effect and interactions of barn and supplement with the covariance of initial serology variable.
b Values are in bold for easy differentiation of parameters with statistical signiﬁcance between treatments.
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of immunity protection for neonates [38,39]. Failure of
passive transfer increases risk of mortality [40] and
morbidity due to increased susceptibility to pathogens
and subsequent disease [41,42]. In this study, we
observed 10 foals distributed equally between both sup-
plement groups with serum IgG concentration below
8 mg/mL, which may indicate failure of passive transfer.
From these 10 foals with lower IgG values at birth, seven
were located in BH barn. Foals are not able to develop
their own immunity until their immune system is fully
developed, and as expected, the IgG values start to in-
crease at 2 months of life, indicating that the immune
capacity of foals was starting to mature, such that foals
were able to produce their own antibodies. No correlation
between IgG levels at birth and medication was observed
in this study.
TNF-a for foals were in general lower than for mares,
indicating most likely that these foals were not very stressed
in this study. However, TNF-a in foals was higher (P < .05) at
birth, probably indicating stress of foals during delivery, as
reduced values were observed after 1 month of life. Also,
absorption of TNF-a from maternal colostrum has been
suggested by Secor et al [43] to potentially cause increased
TNF-a in serum of foals. Interestingly, the TNF-a values had a
tendency to be lower in foals from mares dosed with Bio-
Thrive at birth (P ¼ .097) and continued to be numericallylower during the ﬁrst 30 days of age. This may indicate a
correlation with the lower level of TNF-a from mares dosed
with BioThrive and therefore may suggest lower transfer of
TNF-a throughout maternal colostrum, although the
maternal colostrum was not collected from mares to prove
this hypothesis. No differences were observed for TNF-a
between the two different barns.
No differences were observed in SAA in foals regardless
of their supplement group or barn. However, the values of
SAA were higher at birth and during the ﬁrst 30 days
(P < .05), then declined substantially during the second
month (Table 6). This may indicate the stress associated
with parturition. The SAA results reported in this study for
foals at birth and during the ﬁrst month of life are higher
than other results reported for foals from 0 to 1 month of
life [35]. This may indicate a high stress or inﬂammation of
the foals involved in our study. At 2 months of life, the SAA
values were within the reference values reported for foals
of similar age [35].
4. Conclusions
Under the conditions of this study, there was no
improvement in BW of foals from the use of BioThrive
supplement dosed to their mares. The increased serum IgG
of mares at parturition suggests that supplementationwith
BioThrive during pregnancy may support a more robust
J. Polo et al. / Journal of Equine Veterinary Science 46 (2016) 54–6362immune response. Although nonsigniﬁcant, the tendency
for lower TNF-a for mares during pregnancy along with a
tendency for lower TNF-a observed at birth in foals from
mares dosed with BioThrive may suggest less inﬂammation
during pregnancy and parturition associated with
BioThrive-supplemented mares. Further research would be
needed to determine whether BioThrive supplementation
during pregnancy could potentially impact transfer of
immune competence to the foal.
In addition, we provided speciﬁc reference values for
BW changes and biochemical parameters analyzed for
mares and foals during different periods ranging from
60 days before and after delivery for mares and from birth
to 60 days for foals. Some statistical differences over the
different periods were observed in glucose, urea, and SAA
for mares and glucose, urea, uric acid, cortisol, IgG, TNF-a,
and SAA for foals.Acknowledgments
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